Cancer immunoediting in malignant glioma (Q37986999)

26 August 2017

title

Cancer immunoediting in malignant glioma (English)

1 reference

26 August 2017

Gavin P Dunn

1

1 reference

26 August 2017

Peter E Fecci

series ordinal

2

1 reference

26 August 2017

William T Curry

series ordinal

3

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 August 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

71

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

201-22; discussion 222-3

1 reference

Cancer immunoediting: from immunosurveillance to tumor escape

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Immunotherapy of malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Brain tumor immunotherapy: an immunologist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Basic concepts of immunology and neuroimmunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Inflammation meets cancer, with NF-κB as the matchmaker

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Interferon-gamma and cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

IMMUNOLOGICAL FACTORS IN THE PROCESS OF CARCINOGENESIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Immunological aspects of malignant disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Tumor Development after 3-Methylcholanthrene in Immunologically Deficient Athymic-Nude Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Decreased tumor surveillance in perforin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Model predicting survival in stage I melanoma based on tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Paraneoplastic syndromes of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Cytokines in cancer pathogenesis and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Rules for making human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Genetic instability and darwinian selection in tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

RAG-1-deficient mice have no mature B and T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

A critical function for type I interferons in cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Suppression of lymphoma and epithelial malignancies effected by interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Adaptive immunity maintains occult cancer in an equilibrium state

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Cerebral glial tumors and human immunodeficiency virus-1 infection. More than a coincidental association

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Primary intracranial neoplasms in patients with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Gliomas following organ transplantation: analysis of the contents of a tumor registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Glioblastoma in kidney transplant recipients. Report of five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Capillary Ultrastructure and the Blood-Brain Barrier in Human Malignant Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Vascular microenvironment in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

A listing of human tumor antigens recognized by T cells: March 2004 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

A new era for cancer immunotherapy based on the genes that encode cancer antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

EphA2 as a glioma-associated antigen: a novel target for glioma vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

AIM-2: a novel tumor antigen is expressed and presented by human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Expression of the tumor-rejection antigen SART1 in brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

The DNA demethylating agent 5-aza-2'-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Recognition of ADP-ribosylation factor 4-like by HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes from patients with brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

UDP-Gal: betaGlcNAc beta1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Identification of EGFRvIII-derived CTL epitopes restricted by HLA A0201 for dendritic cell based immunotherapy of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Identification of a human glioma antigen, SOX6, recognized by patients' sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Expression of a transcriptional factor, SOX6, in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Glioma-expressed antigen 2 (GLEA2): a novel protein that can elicit immune responses in glioblastoma patients and some controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Tumor and viral recognition by natural killer cells receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

EGF mutant receptor vIII as a molecular target in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Malignant astrocytic glioma: genetics, biology, and paths to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Molecular pathology of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Immune responses of breast cancer patients to mutated epidermal growth factor receptor (EGF-RvIII, Delta EGF-R, and de2-7 EGF-R).

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Cell surface antigens of human astrocytoma defined by mouse monoclonal antibodies: identification of astrocytoma subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Expression of SoxE and SoxD genes in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Immunobiological characterization of cancer stem cells isolated from glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Role of cervical lymph nodes in the systemic humoral immune response to human serum albumin microinfused into rat cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Physiology and immunology of lymphatic drainage of interstitial and cerebrospinal fluid from the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Initiation of immune responses in brain is promoted by local dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Intratumoral dendritic cell vaccination elicits potent tumoricidal immunity against malignant glioma in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Cutting edge: cross-presented intracranial antigen primes CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Immune cell migration in inflammation: present and future therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Three or more routes for leukocyte migration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Molecular mechanisms involved in T cell migration across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Lymphocytic infiltration in gliomas: evidence of possible host resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Relationship of lymphocyte invasion and survival of brain tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

The mononuclear cell infiltrate compared with survival in high-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Prognostic value of round cell (lymphocyte) infiltration in malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Emerging insights into the molecular and cellular basis of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Immune-mediated dormancy: an equilibrium with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Tumor dormancy in vivo by prevention of neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Immunologically-mediated restraint of latent tumour metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Cancer dormancy: opportunities for new therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

The pathways of extraneural spread in metastasizing gliomas: a report of three cases and critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Extraneural metastases of astrocytomas and glioblastomas: clinicopathological study of two cases and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Transmission of glioblastoma multiforme through liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Glioblastoma multiforme of donor origin after renal transplantation: report of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Accidental transplantation of tumor cells from donors with primary central nervous system tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Immune defects observed in patients with primary malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Hide-and-seek in the brain: a role for HLA-G mediating immune privilege for glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Activation of immunoregulatory lymphocytes obtained from patients with malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Glioma-associated cancer-initiating cells induce immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

The transcriptional network for mesenchymal transformation of brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Promiscuity and the single receptor: NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Impaired thymus-derived lymphocyte function in patients with malignant brain tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Immunobiology of primary intracranial tumors. VI. Suppressor cell function and lectin-binding lymphocyte subpopulations in patients with cerebral tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Letter: Impaired cell-mediated immunity in human brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Transforming growth factor-beta 2 down-regulates HLA-DR antigen expression on human malignant glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Regulatory T cells and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Saying the 'S' word in public.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Self tolerance and localized autoimmunity. Mouse models of autoimmune disease that suggest tissue-specific suppressor T cells are involved in self tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8(-) thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Differential effect of neonatal thymectomy on systemic and organ-specific autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Peptide specificity of thymic selection of CD4+CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Natural regulatory T cells: mechanisms of suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Prognostic significance and mechanism of Treg infiltration in human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Heat-shock protein vaccines as active immunotherapy against human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Cutting Edge: TGF- Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31824F840D

10.1227/NEU.0B013E31824F840D

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference